clinical ffeatures
helps confirm diagnosis
chest X-ray
Subtopic 2
cough
sputum production
dyspnoea
s
chest pain
fever
fatigue
tachycardia
tachypnoea
pyrexia
decreased breath sounds
crepitations
at home or in-patient determines site of care
extent of micro work up
choice of empiric therapy
CURB-65 severity score
co-infection not common in COVID-19
mixed viral and bacterial
pneumonia
common bacterial cause
gram +ve diplococci
immunologic protection through antibodies
streptococcus pne
agaisnts capsular polysaccharides
effective in preventing pneumococcal
pneumonia, invasive pneumococcal disease &
otitis media
herd immunity pneumococcal conjugate vaccine in SA
>92 serotypes serotype replacement
Haemophilus in
gram +ve cocci in clusters
helps confirm diagnosis
chest X-ray
Subtopic 2
cough
sputum production
dyspnoea
s
chest pain
fever
fatigue
tachycardia
tachypnoea
pyrexia
decreased breath sounds
crepitations
at home or in-patient determines site of care
extent of micro work up
choice of empiric therapy
CURB-65 severity score
co-infection not common in COVID-19
mixed viral and bacterial
pneumonia
common bacterial cause
gram +ve diplococci
immunologic protection through antibodies
streptococcus pne
agaisnts capsular polysaccharides
effective in preventing pneumococcal
pneumonia, invasive pneumococcal disease &
otitis media
herd immunity pneumococcal conjugate vaccine in SA
>92 serotypes serotype replacement
Haemophilus in
gram +ve cocci in clusters
